“I’m looking through you”: What consumers and manufacturers need to know about non-invasive diagnostic tests for endometriosis

In: Journal of Endometriosis and Uterine Disorders · 2023 · vol. 2 , pp. 100031 · doi:10.1016/j.jeud.2023.100031 · W4380087970
OA: diamond CC0 ⤵ 5 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This paper discusses the upcoming rise of non-invasive endometriosis diagnostics for screening, warning of potential overdiagnosis and overtreatment in asymptomatic individuals.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Consequences of the shift from the use of non-invasive testing for diagnosis to screening purposes • As the high-throughput screening and sequencing become increasingly faster and affordable, that there will be a swell of commercial non-invasive diagnostic tests for endometriosis in the coming years to fill the void. • Overdiagnosis is common when introducing a novel diagnostic test and overdiagnosis leads to overtreatment that provides, by definition, no benefit at all but that can cause harm and incur expenses. • The shift from the use of non-invasive testing for diagnostic purposes (i.e.use in symptomatic women) to screening purposes (i.e., use in asymptomatic women) is very likely. • In presence of pain symptoms, endometriosis must be promptly suspected and clinically diagnosed regardless of imaging findings and non-invasive diagnostic testing.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (36)

Cited by (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK